Melanotan I vs Melanotan II: A Research Comparison
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
- What they are: Melanotan I and Melanotan II are two lab-made copies of a natural body signal (alpha-MSH) that affects skin pigment. Melanotan I is more targeted; Melanotan II acts on more receptors. They are different compounds, not the same thing.
- What the research shows: most of the science is preclinical, meaning lab dishes and animal studies, not controlled human trials. For example, one rodent study found Melanotan II reduced food-seeking behavior. These are early, hypothesis-building findings that do not prove anything works in people.
- Honest on evidence and safety: a regulated version of Melanotan I (afamelanotide) has been studied in humans for a rare light-sensitivity condition, but the unregulated Melanotan products sold online have been flagged by health agencies for purity and safety problems, including reports of changing moles, nausea, and more serious effects.
- Status: no compound discussed here is approved for human or veterinary use, and nothing in the article is medical advice. Community and social-media accounts are unverified anecdotes, not proof.
- BioRegen sells these strictly for laboratory and educational research only, makes no claim that they work, and gives no human dosing or instructions for use.
Melanotan I and Melanotan II are two lab-made copies of a natural body signal called alpha-melanocyte-stimulating hormone, or alpha-MSH for short. They come up together a lot in research because they are built from the same starting point but are not identical. They reach slightly different targets in the body and have a slightly different shape, so scientists like to line them up and study them side by side. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This article walks through how the two are described in published studies, how they differ, and what the research itself says it cannot yet tell us.
What Melanotan I and Melanotan II Are
Both are made in a lab to copy a natural body signal, alpha-MSH. Think of these signals as keys, and the body has several matching locks (called melanocortin receptors). Melanotan I is a straight-chain peptide. In medical journals the regulated drug version of it is called afamelanotide. Melanotan II is a ring-shaped peptide. In published studies, Melanotan I is usually described as a more picky key that fits mainly one lock, while Melanotan II is described as a broader key that fits several locks, known by the names MC1R, MC3R, and MC4R. Scientists study these shape differences to learn how a peptide's design changes which locks it opens and what happens next inside the cell.
How They Work and What Research Looks At
This family of body signals (the melanocortin system) is studied for its role in skin color, in how the body manages energy, and in signals inside the brain. Research on Melanotan I has looked at the MC1R lock and how it ties into skin color and possible protection from sun. Because Melanotan II fits more locks, it shows up in early animal and lab studies that look at the MC3R and MC4R locks. According to PubMed, one study in rodents reported that when Melanotan II was placed directly into a small reward area of the brain, the animals worked less hard to get food and ate less, while their overall energy burn stayed the same. That shows how researchers use it as a tool to poke at brain signals in animals. Other studies have looked at Melanotan II in animal models of heat production by the body. These are early, question-raising studies meant to explain how things work. They are not proof of any use in people.
Research Stage and Limitations
Most of what compares these two peptides comes from early work: tests on cells in a dish and studies in animals, not in people. The regulated drug version, afamelanotide, has gone through human studies for certain rare conditions where skin reacts badly to light. But the unregulated products sold as Melanotan I or II outside of controlled settings have been called out in the science press for problems with quality, purity, and safety. Researchers also point out that these keys can fit locks they were not meant for, that the quality of unregulated material varies from batch to batch, and that animals and people are not the same. A result in one setting does not carry over to another, and nothing here should be read as a recommendation to use these compounds.
Handling and Laboratory Notes
Both come as a dry powder (freeze-dried). Lab guides usually say to keep them cold and to mix them carefully back into liquid before using them in experiments. In the lab, researchers turn the powder into a liquid using bacteriostatic water, following standard steps. Our overview of how to reconstitute peptides covers the general ideas behind this kind of handling. If you are comparing these signals in the wider area of weight and metabolism research, you may also find background in our piece on retatrutide vs tirzepatide vs semaglutide. Online forums sometimes pass around personal stories comparing the two peptides. Those are unverified personal accounts, not controlled studies, and BioRegen does not make or back any claims based on them.
Is Melanotan I the same as Melanotan II?
No. They are two different lab-made copies of alpha-MSH. They have different shapes and fit a different set of locks in the body, which is why researchers treat them as separate compounds.
Why do researchers compare the two?
Putting a picky key next to a broader key helps scientists figure out which lock is responsible for a given result in their lab or animal models.
Are these compounds approved for use?
No compound referenced here is approved for human or veterinary use. Materials of this type are intended strictly for laboratory and educational research.
Planning a melanocortin research project? Explore our research guide and create a free account for 10% off your first order. To compare reference materials by research goal, try the research finder, or browse the libido research category for related melanocortin-pathway compounds.
Selected research references
- Langan EA, Nie Z, Rhodes LE. Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'? Br J Dermatol. 2010. https://doi.org/10.1111/j.1365-2133.2010.09891.x
- Eliason NL, Martin L, Low MJ, Sharpe AL. Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food. Neuropeptides. 2022. https://doi.org/10.1016/j.npep.2022.102289
Reference metadata sourced via PubMed.
This article is provided for laboratory and educational research purposes only. No compound discussed is approved for human or veterinary use, none is intended to diagnose, treat, cure, or prevent any disease, and nothing here constitutes medical advice. References to research describe published findings and do not imply any safe or effective use outside a controlled research setting.
